1. Home
  2. CATX vs HYLN Comparison

CATX vs HYLN Comparison

Compare CATX & HYLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CATX
  • HYLN
  • Stock Information
  • Founded
  • CATX 1983
  • HYLN 2018
  • Country
  • CATX United States
  • HYLN United States
  • Employees
  • CATX N/A
  • HYLN N/A
  • Industry
  • CATX Medical/Dental Instruments
  • HYLN Construction/Ag Equipment/Trucks
  • Sector
  • CATX Health Care
  • HYLN Consumer Discretionary
  • Exchange
  • CATX Nasdaq
  • HYLN Nasdaq
  • Market Cap
  • CATX 239.0M
  • HYLN 279.7M
  • IPO Year
  • CATX N/A
  • HYLN N/A
  • Fundamental
  • Price
  • CATX $3.67
  • HYLN $1.41
  • Analyst Decision
  • CATX Strong Buy
  • HYLN Hold
  • Analyst Count
  • CATX 11
  • HYLN 1
  • Target Price
  • CATX $12.90
  • HYLN $2.00
  • AVG Volume (30 Days)
  • CATX 954.5K
  • HYLN 904.1K
  • Earning Date
  • CATX 08-13-2025
  • HYLN 08-12-2025
  • Dividend Yield
  • CATX N/A
  • HYLN N/A
  • EPS Growth
  • CATX N/A
  • HYLN N/A
  • EPS
  • CATX N/A
  • HYLN N/A
  • Revenue
  • CATX $1,471,000.00
  • HYLN $1,998,000.00
  • Revenue This Year
  • CATX N/A
  • HYLN $575.94
  • Revenue Next Year
  • CATX $11.99
  • HYLN $255.00
  • P/E Ratio
  • CATX N/A
  • HYLN N/A
  • Revenue Growth
  • CATX N/A
  • HYLN 451.93
  • 52 Week Low
  • CATX $1.60
  • HYLN $1.11
  • 52 Week High
  • CATX $16.55
  • HYLN $4.10
  • Technical
  • Relative Strength Index (RSI)
  • CATX 44.88
  • HYLN 42.57
  • Support Level
  • CATX $3.88
  • HYLN $1.54
  • Resistance Level
  • CATX $4.28
  • HYLN $1.85
  • Average True Range (ATR)
  • CATX 0.27
  • HYLN 0.10
  • MACD
  • CATX -0.08
  • HYLN -0.02
  • Stochastic Oscillator
  • CATX 2.32
  • HYLN 2.22

About CATX Perspective Therapeutics Inc.

Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

About HYLN Hyliion Holdings Corp.

Hyliion Holdings Corp provides solutions that enable clean, flexible, and affordable electricity production. The Company focuses on delivering distributed power generators that can operate on various fuel sources to future-proof against an ever-changing energy economy. It is initially targeting the commercial and waste management industries with a locally deployable generator that can offer prime power as well as energy arbitrage opportunities. In addition to stationary power solutions, it focuses on mobile applications, including vehicles and marine technologies.

Share on Social Networks: